<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="622">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04422379</url>
  </required_header>
  <id_info>
    <org_study_id>COVID 19/LI/2020</org_study_id>
    <nct_id>NCT04422379</nct_id>
  </id_info>
  <brief_title>COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study</brief_title>
  <official_title>COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Max Healthcare Insititute Limited</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Max Healthcare Insititute Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 and liver injury in patients with or without underlying liver disease: A
      multi-centre retrospective-prospective observational study.

      All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital
      Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty
      Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020-
      30/5/2020 &amp; prospective data from approval till 30/6/2020), will be included
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COVID-19 and liver injury in patients with or without underlying liver disease: A
      multi-centre retrospective-prospective observational study.

      All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital
      Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty
      Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020-
      30/5/2020 &amp; prospective data from approval till 30/6/2020), will be included Primary
      objectives

        1. To study the prevalence of liver live injury &amp; factors associated with among patients
           in-fected with SARS-CoV-2.

        2. To study the prevalence of new liver injury and factors associated with it, among
           patient with underlying liver disease who develops COVD-19.

      Secondary objectives

        1. To correlate the presence and degree of liver dysfunction with the clinical outcomes in
           these patients.

        2. To define the incidence of development of acute liver failure among these patients
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 7, 2020</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>COVID-19 Positive Case</measure>
    <time_frame>4-8 weeks</time_frame>
    <description>To study the prevalence of liver live injury &amp; factors associated with among patients in-fected with SARS-CoV-2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COVID-19 Positive Case</measure>
    <time_frame>4-8 weeks</time_frame>
    <description>To study the prevalence of new liver injury and factors associated with it, among patient with underlying liver disease who develops COVID-19.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>COVID-19 Positive Case</measure>
    <time_frame>4-8 weeks</time_frame>
    <description>To correlate the presence and degree of liver dysfunction with the clinical outcomes in these patients.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COVID-19 Positive Case</measure>
    <time_frame>4-8 weeks</time_frame>
    <description>To define the incidence of development of acute liver failure among these patients</description>
  </secondary_outcome>
  <enrollment type="Anticipated">314</enrollment>
  <condition>COVID-19</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will include all the COVID 19 patients (male &amp; female) with minimum
        age 18 years old. And take 60% patient in Retrospective arm and 40% patient in prospective
        arm.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:All patients infected with SARS-CoV-2 and admitted to the COVID-19
        ward/ICU of Max Hospital Saket (either in East Wing , Max Super Specialty Hospital, Saket
        or MAX Smart Super Specialty Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective
        data between 1/4/2020- 30/5/2020 &amp; prospective data from approval till 30/6/2020), will be
        included.

        -

        Exclusion Criteria:

          1. Patients less that 18 years old with COVID-19

          2. Pregnant ladies with COVD-19

          3. Unwilling to give consent for inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaushal Madan, DM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Max healthcare</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaushal Madan, DM</last_name>
    <phone>9958787720</phone>
    <email>K_madan_2000@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vivek Raj, DM</last_name>
    <phone>9818921051</phone>
    <email>Vivek.Raj@maxhealthcare.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Max Super Speciality Hospital, Saket (A Unit Of Devki Devi Foundation)</name>
      <address>
        <city>New Delhi</city>
        <state>Dlelhi</state>
        <zip>110017</zip>
        <country>India</country>
      </address>
    </facility>
    <contact>
      <last_name>Rajesh Saxena</last_name>
      <phone>9818474003</phone>
      <email>Rajesh.saxena@maxhealthcare.com</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 7, 2020</study_first_submitted>
  <study_first_submitted_qc>June 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 7, 2020</last_update_submitted>
  <last_update_submitted_qc>June 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD sharing protocol is undecided at this stage. We may, however, provide the data if requested.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

